COPB2 and hepatocellular carcinoma: Among the 114 HCC specimens in the training group, the COPB2 low and high expression rates were 43.9% (50/114) and 56.1% (64/114), respectively, while the YAP1 low and high expression rates were 42.1% (48/114) and 57.9% (66/114), respectively.